Active, not recruiting
Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
NCT05923190
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Urothelial Carcinoma, +5 more
- Locations
-
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States